Edition:
United Kingdom

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

300.00SEK
23 Feb 2018
Change (% chg)

-2.00kr (-0.66%)
Prev Close
302.00kr
Open
304.00kr
Day's High
307.50kr
Day's Low
300.00kr
Volume
86,106
Avg. Vol
13,507
52-wk High
378.00kr
52-wk Low
240.00kr

Chart for

About

Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that... (more)

Overall

Beta: 1.03
Market Cap(Mil.): kr1,240.39
Shares Outstanding(Mil.): 4.79
Dividend: 1.40
Yield (%): 0.54

Financials

  Industry Sector
P/E (TTM): -- 148.59 16.60
EPS (TTM): -- -- --
ROI: -- 9.38 10.66
ROE: -- 14.72 14.30

BRIEF-Boule Diagnostics Q4 Operating Profit Rises To SEK ‍14.9​ Million

* Q4 NET SALES SEK ‍107.2​ MILLION VERSUS SEK 104.6 MILLION YEAR AGO

16 Feb 2018

BRIEF-Boule Diagnostics Q3 operating profit grows to SEK ‍28.2​ mln

* Q3 NET SALES SEK ‍109.7​ MILLION VERSUS SEK 108.5 MILLION YEAR AGO

08 Nov 2017

BRIEF-Boule Diagnostics appoints ‍christina Rubenhag new CFO

* ‍CHRISTINA RUBENHAG NEW CFO FROM OCT.9 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

20 Sep 2017

BRIEF-Boule Diagnostics Q2 net result swings to loss SEK 1.1 mln

* Q2 NET SALES SEK ‍104.3​ MILLION VERSUS SEK 102.0 MILLION YEAR AGO

25 Aug 2017

Earnings vs. Estimates